TNFRSF1B and lung carcinoma: Furthermore, the expression of TNFR2 on Tregs is associated with greater lymphatic invasion, a higher incidence of tumor metastasis, a higher clinical stage, and poorer response to the treatment in patients with lung cancer and acute myeloid leukemia (31, 34, 35).